Guru Ownership Trend
Guru Analysis for Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $0.
Top institutional holders include Steven Cohen and Renaissance Technologies.
Institutional sentiment is currently Bullish. This is evidenced by a $2.65 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Xilio Therapeutics, Inc. (XLO)
Major holders include Steven Cohen ($2.56 M), Renaissance Technologies ($220,495). According to the latest reported data, 2 tracked investment managers collectively hold approximately 4.34 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.65 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in XLO during the most recent reporting period.
Yes, 1 managers opened new positions in XLO, and 1 increased their existing holdings. The total reported buy value was $2.65 M.